223 related articles for article (PubMed ID: 31823509)
1. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related adverse reactions in the nervous system.
Shi J; Niu J; Shen D; Liu M; Tan Y; Li Y; Huang Y; Cui L; Guan Y; Zhang L
Thorac Cancer; 2020 Feb; 11(2):481-487. PubMed ID: 31823509
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Diagnosis and Treatment Recommendations for Adverse Reaction in the Nervous System Related to Immunocheckpoint Inhibitor].
Shi J; Niu J; Shen D; Li Y; Liu M; Tan Y; Cui L; Guan Y; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Oct; 22(10):633-638. PubMed ID: 31650945
[TBL] [Abstract][Full Text] [Related]
3. Clinical diagnosis and treatment of immune checkpoint inhibitors-related endocrine dysfunction.
Duan L; Wang L; Wang H; Si X; Zhang L; Liu X; Li Y; Guo X; Zhou J; Zhu H; Zhang L
Thorac Cancer; 2020 Apr; 11(4):1099-1104. PubMed ID: 32043816
[TBL] [Abstract][Full Text] [Related]
4. Management of immune checkpoint inhibitor-related dermatologic adverse events.
Si X; He C; Zhang L; Liu X; Li Y; Wang H; Guo X; Zhou J; Duan L; Wang M; Zhang L
Thorac Cancer; 2020 Feb; 11(2):488-492. PubMed ID: 31814310
[TBL] [Abstract][Full Text] [Related]
5. Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections.
Lu M; Zhang L; Li Y; Wang H; Guo X; Zhou J; Duan L; Si X; Xu Y; Zhang L
Thorac Cancer; 2020 Mar; 11(3):805-809. PubMed ID: 31970940
[TBL] [Abstract][Full Text] [Related]
6. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events.
Zhuang J; Du J; Guo X; Zhou J; Duan L; Qiu W; Si X; Zhang L; Li Y; Liu X; Wang H; Zhou D; Zhang L
Thorac Cancer; 2020 Mar; 11(3):799-804. PubMed ID: 32017466
[TBL] [Abstract][Full Text] [Related]
7. Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy.
Liu X; Wang Z; Zhao C; Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Li Y; Wang M; Zhang M; Zhang L
Thorac Cancer; 2020 Mar; 11(3):810-818. PubMed ID: 32017399
[TBL] [Abstract][Full Text] [Related]
8. Management of immune checkpoint inhibitor-related rheumatic adverse events.
Zhou J; Wang H; Guo X; Wang Q; Duan L; Si X; Zhang L; Liu X; Li Y; Zhang W; Zhang L
Thorac Cancer; 2020 Jan; 11(1):198-202. PubMed ID: 31762209
[TBL] [Abstract][Full Text] [Related]
9. Neurological immune-related adverse events associated with immune checkpoint inhibitors: A review of the literature.
Fan S; Ren H; Zhao L; Yin J; Feng G; Wang J; Guan H
Asia Pac J Clin Oncol; 2020 Dec; 16(6):291-298. PubMed ID: 32893999
[TBL] [Abstract][Full Text] [Related]
10. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
Sato K; Mano T; Iwata A; Toda T
J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
[TBL] [Abstract][Full Text] [Related]
11. Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis.
Wang H; Guo X; Zhou J; Li Y; Duan L; Si X; Zhang L; Liu X; Wang M; Shi J; Zhang L
Thorac Cancer; 2020 Jan; 11(1):191-197. PubMed ID: 31762218
[TBL] [Abstract][Full Text] [Related]
12. Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor-induced renal immune-related adverse events.
Zheng K; Qiu W; Wang H; Si X; Zhang X; Zhang L; Li X
Thorac Cancer; 2020 Jun; 11(6):1746-1751. PubMed ID: 32232975
[TBL] [Abstract][Full Text] [Related]
13. Clinical diagnosis and treatment of immune checkpoint inhibitor-associated adverse events in the digestive system.
Li Y; Kang X; Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Liu X; Qian J; Zhang L
Thorac Cancer; 2020 Apr; 11(4):829-834. PubMed ID: 32107847
[TBL] [Abstract][Full Text] [Related]
14. Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials.
Bruna J; Argyriou AA; Anastopoulou GG; Alemany M; Nadal E; Kalofonou F; Piulats JM; Simó M; Velasco R; Kalofonos HP
J Peripher Nerv Syst; 2020 Jun; 25(2):171-177. PubMed ID: 32166812
[TBL] [Abstract][Full Text] [Related]
15. Neurological adverse events of immune checkpoint inhibitors: An update of clinical presentations, diagnosis, and management.
Farina A; Villagrán-García M; Honnorat J
Rev Neurol (Paris); 2023 Jun; 179(5):506-515. PubMed ID: 36934022
[TBL] [Abstract][Full Text] [Related]
16. Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.
Pan PC; Haggiagi A
Curr Oncol Rep; 2019 Nov; 21(12):108. PubMed ID: 31776691
[TBL] [Abstract][Full Text] [Related]
17. Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review.
Marini A; Bernardini A; Gigli GL; Valente M; Muñiz-Castrillo S; Honnorat J; Vogrig A
Neurology; 2021 Apr; 96(16):754-766. PubMed ID: 33653902
[TBL] [Abstract][Full Text] [Related]
18. Management of immune checkpoint inhibitor-related adverse events: A review of case reports.
Si X; Song P; Ni J; Di M; He C; Zhang L; Liu X; Li Y; Wang H; Guo X; Zhou J; Duan L; Yang X; Wang M; Zhang L
Thorac Cancer; 2020 Mar; 11(3):498-504. PubMed ID: 31970923
[TBL] [Abstract][Full Text] [Related]
19. [Distinctive Disease Entity of Neurological Adverse Events Associated with Immune Checkpoint Inhibitors].
Seki M; Suzuki S
Brain Nerve; 2021 Jan; 73(1):35-46. PubMed ID: 33361512
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.
Reynolds KL; Guidon AC
Oncologist; 2019 Apr; 24(4):435-443. PubMed ID: 30482825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
